NCT06915753
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06915753
Title Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations (SURF431)
Acronym SURF431
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Tyra Biosciences, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
USC Norris Comprehensive Cancer Center RECRUITING Los Angeles California 90033 United States Details
UCSF Medical Center at Mount Zion RECRUITING San Francisco California 94158 United States Details
Stanford Cancer Institute RECRUITING Stanford California 94305 United States Details
The University of Kansas Medical Center RECRUITING Westwood Kansas 66205 United States Details
John Hopkins University RECRUITING Baltimore Maryland 21205 United States Details
Mass General Cancer Center RECRUITING Boston Massachusetts 02114 United States Details
Karmanos Cancer Institute RECRUITING Detroit Michigan 48201 United States Details
Columbia University Irving Medical Center RECRUITING New York New York 10043 United States Details
Sarah Cannon Research Institute Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
University Health Network Princess Margaret Cancer Center RECRUITING Toronto Ontario M5G 2C4 Canada Details
Asan Medical Center RECRUITING Seoul South Korea Details
Samsung Medical Center RECRUITING Seoul South Korea Details
Seoul National University Hospital RECRUITING Seoul South Korea Details
Severance Hospital, Yonsei University Health System RECRUITING Seoul South Korea Details
National Taiwan University Hospital RECRUITING Taipei Taiwan Details
Taipei Veterans General Hospital RECRUITING Taipei Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field